Abstract
Background:Glucocorticoids (GCs) are still the mainstay during treatment of systemic lupus erythematosus (SLE). However, since their long-term side effects are well known, GC discontinuation is becoming a crucial part of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
